Tjoelker et al. Nature vol. 374 : pp. 549-553 (1995). |
Adjei et al., "Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers," Pharm. Res., 7(6):565-569 (1990). |
Braquet et al., "Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig," J. Cardio. Pharm., 13 (Supp. 5):S143-S146 (1989). |
Brenner, "The Molecular Evolution of Genes and Proteins: A Tale of Two Serines," Nature, 334:528-530 (Aug. 11, 1988). |
Capecchi, "Altering the Genome by Homologous Recombination," Science, 244:1288-1292 (Jun. 16, 1989). |
Chapus et al., "Minireview on Pancreatic Lipase and Colipase," Biochimie, 70:1223-1224 (1988). |
deBoer et al., "The tac Promoter: A Functional Hybrid Derived From the trp and lac Promoters," Proc. Nat'l Acad. Sci., USA, 80:21-25 (Jan. 1983). |
Debs et al., "Lung-Specific Delivery of Cytokines Induces Sustained Pulmonary and Systemic Immunomodulation in Rats," J. Immunol., 140(10):3462-3488 (May 15, 1933). |
Denizot et al., "PAF-Acether and Acetylhydrolase in Stool of Patients with Crohn's Disease," Digestive Diseases and Sciences, 37(3):432-437 (Mar., 1992). |
Furukawa et al., "Platelet-Activating Factor-Induced Ischemic Bowel Necrosis: The Effect of Platelet-Activating Factor Acetylhydrolase," Ped. Res., 34(2):237-241 (1993). |
Grino et al., "BN 52021: A Platelet Activating Factor Antagonist for Preventing Post-Transplant Renal Failure," Anna. Int. Med., 121(5):345-347 (Sep. 1, 1994). |
Handley and Saunders, "Platelet Activating Factor and Inflammation in Atherogenesis: Targets for Drug Development," Drug. Dev. Res., 7:361-375 (1986). |
Hattori et al., "Purification and Characterization of Bovine Brain Platelet-activating Factor Acetylhydrolase," J. Biol. Chem., 268(25):18748-18753 (Sep. 5, 1993). |
Hattori et al., "The Catalytic Subunit of Bovine Brain Platelet-activating Factor Acetylhydrolase Is a Novel Type of Serine Esterase," J. Biol. Chem., 269(37):23150-23155 (Sep. 16, 1994). |
Henriques et al., "Endothelin-1 Inhibits PAF-induced Paw Oedema and Pleurisy in the Mouse," Br. J. Pharmacol., 106:579-582 (1992). |
Heuer, H. O., "Current Status of PAF Antagonists," Clin. Exp. Allergy, 22:980-983 (1992). |
Hoffman et al., "Detection of Platelet-activating Factor in Amniotic Fluid of Complicated Pregnancies," Am. J. Obstet. Gynecol., 162(2):525-528 (1990). |
Horwitz et al., "DNA Sequencies of the araBAD-araC Controlling Region in Salmonella typhimurium LT2," Gene, 14:309-319 (1981). |
Hsieh and Ng, "Increased Plasma Platelet-activating Factor in Children with Acute Asthmatic Attacks and Decreased in vivo and in vitro Production of Platelet-activating Factor After Immunotherapy," J. Allergy Clin. Immunol., 91:650-657 (Feb. 1993). |
Hsueh et al., "Platelet-activating Factor, Tumor Necrosis Factor, Hypoxia and Necrotizing Enterocolitis," Acta Paediatr., Suppl. 396:11-17 (1994). |
Hubbard et al., "Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in .alpha.1-Antitrypsin Deficiency Directly Augmented with an Aerosol of A1-Antitrypsin," Annals of Internal Medicine, 111(3):206-212 (Aug. 1, 1989). |
Kald et al., "Release of Platelet-Activating Factor in Acute Experimental Pancreatitis," Pancreas, 8(4):440-442 (1993). |
Kurosawa et al., "Increased Levels of Blood Platelet-activating Factor in Bronchial Asthmatic Patients With Active Symptoms," Allergy, 49:60-63 (1994). |
LaVallie et al., "A Thioredoxin Gene Fusion Expression System That Circumvents Inclusion Body Formation in the E. coli Cytoplasm," Bio/Technology, 11:187-193 (Feb. 11, 1993). |
Lewin, B., In: Genes V, Oxford University Press, New York, New York, Chapter 6, pp. 136-140 (1994). |
Lindsberg et al., "Evidence for Platelet-Activating Factor as a Novel Mediator in Experimental Stroke in Rabbits," Stroke, 21(10):1452-1457 (Oct., 1990). |
Lindsberg et al., "Platelet-activating Factor in Stroke and Brain Injury," Ann. Neurol., 30(2):117-129 (Aug., 1991). |
Maki et al., "Platelet-activating Factor Acetylhydrolase Activity in Maternal, Fetal, and Newborn Rabbit Plasma During Pregnancy and Lactation," Proc. Nat'l Acad. Sci., USA, 85:728-732 (Feb., 1988). |
Matsumoto et al., "Platelet-Activating Factor in Bronchoalveolar Lavage Fluid of Patients With Adult Respiratory Distress Syndrome," Clin. Exp. Pharmacol. Physiol., 19:509-515 (1992). |
Matsuzaki et al., "PAF Acetylhydrolase Activities in Human Systemic Lupus Erythematosus and Lupus-prone Mice," Clinica Chimica Acta, 210:139-144 (1992). |
Mezzano et al., "Detection of Platelet-Activating Factor in Plasma of Patients with Streptococcal Nephritis," J. Am. Soc. Nephrol., 4:235-242 (1993). |
Miwa et al., "Characterization of Serum Platelet-activating Factor (PAF) Acetylhydrolase," J. Clin. Invest., 82:1983-1991 (Dec., 1988). |
Rabinovici et al., "ARDS-like Lung Injury Produced by Endotoxin in Platelet-activating Factor-primed Rats," J. Appl. Physiol., 74(4):1791-1802 (1993). |
Rabinovici et al., "Platelet Activating Factor Mediates Interleukin-2-induced Lung Injury in the Rat," J. Clin. Invest., 89:1669-1673 (May, 1992). |
Rodriguez-Roisin et al., "Platelet-activating Factor Causes Ventilation-Perfusion Mismatch in Humans", J. Clin. Invest., 93:188-194 (Jan., 1994). |
Satoh et al., "Platelet-activating Factor (PAF) Stimulates the Production of PAF Acetylhydrolase by the Human Hepatoma Cell Line, HepG2," J. Clin. Invest., 87:476-481 (Feb., 1991). |
Satoh et al., "Platelet-Activating Factor Acetylhydrolase in Plasma Lipoproteins From Patients With Ischemic Stroke," Stroke, 23(8):1090-1092 (1992). |
Smith et al., "Pulmonary Deposition and Clearance of Aerosolized Alpha-1-Proteinase Inhibitor Administered to Dogs and to Sheep," J. Clin. Invest., 84:1145-1154 (Oct., 1989). |
Stafforini et al., "Human Macrophages Secrete Platelet-activating Factor Acetylhydrolase," J. Biol. Chem., 265(17):9682-9687 (Jun. 15, 1990). |
Stafforini et al., "Human Plasma Platelet-activating Factor Acetylhdrolase: Association With Lipoprotein Particles and Role in the Degradation of Platelet-activating Factor," J. Biol. Chem., 262(9):4215-4222 (Mar. 25, 1987). |
Stafforini et al., "Human Plasma Platelet-activating Factor Acetylhydrolase: Purification and Properties," J. Biol. Chem., 262(9):4223-4230 (Mar. 25, 1987). |
Stafforini et al., "Platelet-activating Factor Acetylhydrolase Activity in Human Tissues and Blood Cells," LIPIDS, 26(12):979-985 (1991). |
Stafforini et al., "The Platelet-activating Factor Acetylhydrolase from Human Erythrocytes: Purification and Properties," J. Biol. Chem., 268(6):3857-3865 (Feb. 25, 1993). |
Stafforini et al., "Lipoproteins Alter the Catalytic Behavior of the Platelet-activating Factor Acetylhydrolase in Human Plasma," Proc. Nat'l Acad. Sci., USA, 86:2393-2397 (Apr., 1989). |
Stremler et al., "Human Plasma Platelet-activating Factor Acetylhydrolase," J. Biol. Chem., 266(17):11095-11103 (Jun. 15, 1991). |
Tarbet et al., "Liver Cells Secrete the Plasma Form of Platelet-activating Factor Acetylhydrolase," J. Biol. Chem., 266(25):16667-16673 (Sep., 1991). |
Venable et al., "Platelet-activating Factor: A Phospholipid Autacoid With Diverse Actions," J. Lipid Res., 34:691-701 (1993). |
Von Heijne, "A New Method for Predicting Signal Sequence Cleavage Sites," Nuc. Acids Res., 14(11):4683-4690 (1986). |
Wada et al., "Codon Usage Tabulated from the GenBank Genetic Sequence Data," Nuc. Acids Res., 19S:1981-1986 (1991). |
Watanabe et al., "Pharmacological Analysis of Neutrophil Chemotactic Factor Production by Leucocytes and Roles of PAF in Allergic Inflammation in Rats," Br. J. Pharmacol., 111:123-130 (1994). |
Watson et al., "The Platelet-Activating Factor Antagonist Web 2170 Its Beneficial Effect on Dog Renal Allograft Survival," Transplantation, 56(4):1047-1049 (Oct., 1993). |
Zarco et al., "Involvement of Platelet-activating Factor and Tumor Necrosis Factor in the Pathogenesis of Joint Inflammation in Rabbits," Clin. Exp. Immunol., 88:318-323 (1992). |